Acute inhibition of microsomal drug metabolism by propoxyphene in narcotic tolerant/dependent mice

Propoxyphene (Darvon) was compared to SKF 525-A, a prototypical inhibitor of hepatic microsomal mixed function oxidases, to assess propoxyphene's potential to inhibit drug metabolism in morphine tolerant/dependent mice. $\text{In vitro}$, both propoxyphene (K_i = 3.5 × 10^?5M) and SKF 525-A (K_i = 4.3 × 10^?6M) inhibited the activity of aminopyrine N-demethylase competitively in hepatic microsomes from tolerant/dependent animals. Propoxyphene and SKF 525-A were weaker, noncompetitive inhibitors of aniline hydroxylase activity. $\text{In vivo}$, equimolar doses (0.24 mmoles/kg, i.p.) of each compound inhibited both of the above monooxygenases in the 10,000$\text{g}$ supernatant fractions of livers from the tolerant/ dependent animals. Propoxyphene was 40–50% as potent an inhibitor of these activities as SKF 525-A. A dose (300 mg/kg) of propoxyphene napsylate, shown to prevent narcotic abstinence signs with no observable toxicity in withdrawing mice, significantly prolonged the blood levels of injected pentobarbital and tripled pentobarbital sleeping time in these animals. When administered at 300 mg/kg chronically, propoxyphene napsylate acted as an inducer of its own metabolism. Propoxyphene napsylate, then, given acutely to narcotic tolerant/dependent mice, is a potent inhibitor of microsomal drug metabolizing capacity. Given chronically, it enhances this capability.     

Acceleration of pentobarbital metabolism in tolerant mice induced by pentobarbital pellet implantation

The time course of inductions of N-demethylation and pentobarbital hydroxylation of hepatic drug metabolizing system in continuous pentobarbital administration by pentobarbital pellet implantation in the mouse is presented. The results also demonstrate that hepatic microsomal drug-metabolizing enzymes in the mouse could be induced much faster by a single pentobarbital pellet implantation than by the ordinary parenteral administration technique. The reduction of pentobarbital half-life ($\text{T}\text{1}\text{2}$) in plasma, brain and liver of the animals which had been implanted with a pentobarbital pellet also substantiates the acceleration of pentobarbital metabolism in the mouse by the pellet implantation method. The results show that the $\text{T}\text{1}\text{2}$ of pentobarbital in plasma, brain and liver of pentobarbital pellet implanted groups is only $\text{1}\text{2}\text{,}\text{1}\text{6}\text{and}\text{1}\text{9}$ of that of the placebo control group, respectively. The studies on urinary excretion of pentobarbital and its metabolites also reveals that pentobarbital pellet implantation induced much faster rate of metabolism of pentobarbital in the mouse.     

Absence of ethanol metabolism in "acatalatic" hepatic microsomes that oxidize drugs

When liver slices of Cs^a and Cs^b mice were incubated $\text{in}\text{vitro}$, they had similar catalase activities and equal rates of ethanol metabolism. While incubated liver homogenates and microsomes from Cs^a mice oxidized ethanol and retained catalase activity, preparations from Cs^b mice did not oxidize ethanol and lost all catalase activity. Addition of beef liver catalase restored ethanol oxidation by Cs^b microsomes. The oxidations of aniline and aminopyrine proceeded at the same rate in Cs^a and Cs^b microsomes and were inhibited by ethanol. It is evident that (a) the microsomal drug-metabolizing pathway is not involved in ethanol oxidation, and (b) the postulation of a unique microsomal ethanol-oxidizing system (“MEOS”) that is independent of microsomal catalase is unwarranted.     

Effect of cigarette smoke on drug metabolism in vitro.

N-demethylation of aminopyrine and C-hydroxylation of aniline by hepatic microsomal enzymes were measured during $\text{in vitro}$ exposure to cigarette smoke. Metabolism of aminopyrine during smoke exposure was not significantly altered. Metabolism of aniline during smoke exposure was inhibited 70–80% (P < .001) thus indicating that an initial effect of exposure to cigarette smoke is a decreased rate of biotransformation via C-hydroxylation. This finding, coupled with the findings of other investigators who have shown that the delayed effect of exposure to cigarette smoke is induction of hydroxylase activity, suggests that cigarette smoke produces a biphasic alteration in certain hepatic biotransformation processes.     

Response of the mixed function oxidase system of rat hepatic microsomes to parathion and malathion and their oxygenated analogs

$\text{In}$$\text{vitro}$ inhibition of ethylmorphine metabolism in rat hepatic microsomes by parathion, malathion, malaoxon and paraoxon was not well correlated with their effects on NADPH oxidation, cytochrome C reduction or the reduction of cytochrome P-450. A parallel relationship was observed between inhibition of ethylmorphine metabolism by parathion, malathion and malaoxon and the binding affinity of these agents to microsomal cytochrome P-450 obtained from rats pretreated with an anticholinesterase agent, Bis-[?-nitrophenol] phosphate.     

The interaction of vinyl chloride with rat hepatic microsomal cytochrome P-450 in vitro.

In the presence of hepatic microsomes, vinyl chloride produces a ‘type I’ difference spectrum and stimulates carbon monoxide inhibitable NADPH consumption. A comparison of the binding and Michaelis parameters for the interaction of vinyl chloride with uninduced, phenobarbital and 3-methylcholanthrene induced microsomes indicates that the binding and metabolism of vinyl chloride is catalyzed by more than one type P-450 cytochrome, but predominantly by cytochrome P-450. Metabolites of vinyl chloride from this enzyme system decrease the levels of cytochrome P-450 and microsomal heme, but not cytochrome $\text{b}$₅ or NADPH-cytochrome $\text{c}$ reductase $\text{in vitro}$.     

Investigations into the hepatic metabolism of dimethylnitrosamine in the rat.

In this paper we report the detection and identification of methanol as an intermediate formed during both the $\text{in vivo}$ and the $\text{in vitro}$ metabolism of dimethylnitrosamine (DMN) in the rat. Methanol was formed in both hepatic 10,000 $\text{g}$ av. supernatant and washed microsomal fractions over a wide range of nitrosamine substrate concentrations. Furthermore the total amounts of methanol and formaldehyde formed largely accounted for the metabolic fate of both methyl moieties of DMN. Although a number of inhibitors of alcohol metabolism profoundly inhibited the hepatic metabolism of DMN they had little effect on the activities of two mixed function oxidase dependent enzymes. The results suggest that DMN and possibly other dialkylnitrosamines are degraded by enzymic pathway(s) not dependent on cytochrome P-450.     

Comparison of ratios of covalent binding to total metabolism of the pulmonary toxin, 4-ipomeanol, In vitro in pulmonary and hepatic microsomes,and the effects of pretreatments with phenobarbital or 3-methylcholanthrene

Studies of the ratios of the amounts of 4-ipomeanol covalently bound to the total amounts metabolized support the view that the high rates of $\text{in}\text{vitro}$ pulmonary microsomal alkylation by 4-ipomeanol reflect high rates of NADPH-mediated metabolic activation of the compound rather than a relative deficiency of a microsomal detoxication pathway. Moreover, the ability of 3-methylcholanthene pretreatment, but not phenobarbital pretreatment, to shift the $\text{in}\text{vivo}$ target organ alkylation and toxicity of 4-ipomeanol from the lung to the liver in rats could not be explained by a major alteration in the balances between microsomal toxication and detoxication pathways measurable in the $\text{in}\text{vitro}$ systems examined, nor upon a major change in the nature of the reactive 4-ipomeanol metabolites produced in the lungs or livers of the pretreated animals.     

The degradation of different forms of cytochrome P-450 in vivo by fluroxene and allyl-iso-propylacetamide.

Treatment of uninduced, phenobarbital and 3-methylcholanthrene induced rats with fluroxene and allyl-$\text{iso}$-propylacetamide decreased hepatic microsomal cytochrome P-450 and equivalently decreased microsomal heme, aniline binding and $\text{p}$-nitroanisole demethylase. In contrast, ethylmorpnine demethylase, benzpyrene-3-hydroxylase and ethoxyresofurin deethylase were not in all cases decreased in proportion to the loss of cytochrome P-450. After phenobarbital induction fluroxene and allyl-$\text{iso}$-propylacetamide degrade multiple forms of cytochrome P-450, but degrade in the greatest amounts the form(s) of cytochrome P-450 inducible by phenobarbital. After 3-methylcholanthrene induction fluroxene preferentially degrades cytochrome P-448, while allyl-$\text{iso}$-propylacetamide is relatively specific for the form(s) of cytochrome P-450 inducible by phenobarbital.     

Inhibition of drug metabolism by chronically administered naltrexone

Naltrexone, a long-acting narcotic antagonist, was administered to mice via aong-term delivery system of 1.5 mm beads containing 2 mg of naltrexone in a 90/10 polylactic/glycolic acid copolymer (Dynatech R/D Comp.). A single bead implanted subcutaneously antagonized the analgesic action of interimittently administered morphine sulfate (20 mg/kg, i.p.) for 25–35 days. During this 4–5 week period during which the naltrexone was pharmacologically active, the activities of the hepatic, microsomal mixed function oxidases aminopyrine N-demethylase and aniline hydroxylase were depressed to 30–50% of the levels seen in sham-implanted controls. Hexobarbital sleeping time and zoxazolamine paralysis time were significantly prolonged, and the blood half-lives of ¹⁴C-pentobarbital and ¹⁴H-amphetamine were lengthened when the monoxygenase activities were inhibited. Sleeping time following administration of ethanol was unaffected. $\text{In}$$\text{vitro}$, both naltrexone and its major metabolite, ß-naltrexol, were found to be inhibitory of the activities of aminopyrine N-demethylase and aniline hydroxylase, although the parent compound was the more potent inhibitor of both activities by a factor of 2–3.     

The role of binding in inhibition of hepatic microsomal metabolism by parathion and malathion

Parathion, malathion and their oxygenated analogs bind to the reduced form of cytochrome P-450 from rats and mice producing spectra with a maximum at 421 nm and a minimum at 450 nm. Determinations of microsomal heme suggest that the Soret at 421 nm is not associated with conversion of cytochrome P-450 to cytochrome P-420. $\text{In vivo}$ pretreatment with C¹⁴-parathion indicates that this insecticide covalently binds to mouse hepatic microsomal protein. These findings suggest that the mechanism by which these insecticides and their analogs inhibit hepatic microsomal metabolism is identical to their mode of inhibiting esterases, that is, covalent binding to catalytic site.     

Differential control of adrenal drug and steroid metabolism in the guinea pig.

Studies were carried out to compare the effects of several physiological variables on adrenal microsomal drug (ethylmorphine demethylation) and steroid (21-hydroxylation) metabolism in guinea pigs. The rate of adrenal ethylmorphine (EM) metabolism increased with maturation in males but not females, resulting in a sex difference (M > F) in adrenal enzyme activity in adult guinea pigs. Twenty-one hydroxylase activity, in contrast, was similar in adrenals from males and females. The concentration of adrenal microsomal cytochrome P-450 was unaffected by age or sex. ACTH administration decreased adrenal EM demethylase activity but did not affect 21-hydroxylation. Testosterone, when given to female guinea pigs, increased the rate of EM metabolism and decreased 21-hydroxylase activity. Various compounds known to interact with adrenal microsomal cytochrome P-450 had divergent effects on EM metabolism and 21-hydroxylation $\text{in}$$\text{vitro}$. Prostaglandins E₁ and F_2α, spironolactone, and canrenone inhibited EM demethylation but not 21-hydroxylation. Simple aromatic hydrocarbons (benzene, toluene), in contrast, inhibited 21-hydroxylation but did not affect EM metabolism. The results indicate that adrenal drug and steroid metabolism are independently regulated and that different terminal oxidases (cytochrome P-450) are probably involved in adrenal 21-hydroxylation and EM demethylation.     

Liver damage from cocaine in mice

Four daily injections of 20 mg per kg cocaine hydrochloride into B6AF₁/J mice produced focal necrosis of liver parenchymal cells in the midzonal region. Massive liver damage and marked elevation of serum glutamic-oxaloacetic transaminase was observed after a single injection of 50 mg per kg cocaine-HC1. This damage led to increased sleep time after pentobarbital, and a decreased rate of pentobarbital metabolism $\text{in vivo}$.     

Deuterium-isotope effect in the biotransformation of 4-ethynylbiphenyls to 4-biphenylylacetic acids by rat hepatic microsomes

$\text{In vitro}$ studies using hepatic microsomal homogenate and 4-(1-deuteroethynyl) biphenyls have shown that there is an isotope effect in conversion of 4-ethynylbiphenyls to 4-biphenylylacetic acids. This effect is consistent with mechanisms involving either (1) direct hydroxylation of the ethynyl moiety or (2) oxirene formation followed by a rate-determining hydride shift to form the intermediate ketene.     

Effects of anti-NADPH-cytochrome c reductase and anti-cytochrome b5 antibodies on the hepatic and pulmonary microsomal metabolism and covalent binding of the pulmonary toxin 4-ipomeanol.

An antibody prepared against purified rat liver NADPH-cytochrome $\text{c}$ reductase inhibited both the pulmonary and hepatic microsomal covalent binding of 4-ipomeanol as well as the respective NADPH-cytochrome $\text{c}$ reductase activities, findings which are consistent with previous studies which indicated the participation of cytochrome P450 in the metabolic activation of the toxin. An antibody prepared against purified rat liver cytochrome b₅, which strongly inhibited both the rat hepatic and pulmonary NADH-dependent cytochrome $\text{c}$ reductases, and was inactive against the respective NADPH-dependent cytochrome $\text{c}$ reductases, had little effect on metabolic activation of 4-ipomeanol by hepatic microsomes, but strongly inhibited both the NADH-supported and the NADPH-supported pulmonary microsomal metabolism and covalent binding of the compound. These results suggest that metabolic activation of 4-ipomeanol involves a two-electron transfer in which transfer of the second electron via cytochrome b₅ is rate-limiting in lung microsomes.     

Metabolic activation of procarbazine

Procarbazine chemical degradation and rat $\text{in vitro}$ and $\text{in vivo}$ metabolism have been investigated. Procarbazine was rapidly oxidized to the azo derivative in aqueous solution in the presence of oxygen. $\text{In vitro}$ rat liver supernatany and microsomal preparations oxidize the azo function to azoxy isomers and further hydroxylate these metabolites in a manner that may by analogous to 1,2-dimethylhydrazine metabolism. The hydroxylated metabolites are activated species that chemically react to give methylating and alkylating agents. An additional metabolic pathway was observed $\text{in vivo}$. This suggests that procarbazine may be converted to free radical intermediates that decompose to give methane and N-isopropyltoluamide. Procarbazine metabolites have been separated and identified using high performance liquid chromatography and direct probe chemical ionization mass spectrometry.     

The effect of ethyl-alpha-p-chlorophenoxisobutyrate (clofibrate) on alcohol metabolism

The effect of chronic feeding of ethyl-α-p-chlorophenoxyisobutyrate (clofibrate, CPIB) upon alcohol metabolism has been examined. Clofibrate stimulated both ethanol and methanol oxidation $\text{in vivo}$ and $\text{in vitro}$, differences which were sensitive to 3-amino-1,2,4-triazole, a catalase inhibitor, but not to pyrazole, an inhibitor of alcohol dehydrogenase. These studies suggest that the increased alcohol oxidation associated with clofibrate feeding is related, at least in part, to increased catalatic peroxidation.     

Thyroxine stimulation of rate liver microsomal NADH-cytochrome c reductase in vitro

Rat liver microsomal NADH-cytochrome $\text{c}$ reductase activity is stimulated by 20 μM thyroxine $\text{in}$$\text{vitro}$. Thyroxine does not influence microsomal NADH-dichlorophenolindophenol reductase, NADPH-cytochrome $\text{c}$ reductase, or NADPH-dichlorophenolindophenol reductase activity. Stimulation of NADH-cytochrome $\text{c}$ reductase activity is not mediated by super-oxide and is likely due to enhanced reduction or oxidation of cytochrome $\text{b}$5.     

Selective induction of cytochrome b5 and NADH cytochrome b5 reductase by propylthiouracil

Both the cytochrome b₅ level and NADH cytochrome b₅ reductase activity in rat liver microsomes were increased 2-fold by repeated i.p. administration of 1.5 mmol/kg propylthiouracil (PTU) for 2 weeks, but neither the cytochrome P-450 level nor NADPH cytochrome P-450 reductase activity were affected by the treatment. Liver microsomes from PTU-treated rats showed a significant decrease in aminopyrine N-demethylation, but not in benzphetamine N-demethylation, aniline hydroxylation or 7-ethoxycoumarin O-deethylation. A single administration of the compound had no effect on any components of the system. $\text{In vitro}$, drug hydroxylation activities were not affected by PTU up to 1.0 mM. From the above evidence, repeated administration of PTU selectively induced cytochrome b₅ and NADH cytochrome b₅ reductase in rat liver microsomes.     

The effect of dietary fat on the activity,content, rates of synthesis,and degradation and translation of messenger RNA coding for malic enzyme in mouse liver

The specific activity (units activity/mg cytosolic protein) of malic enzyme was found to be three-fold higher in the livers of mice fed a semipurified diet containing 50% ($\text{w}\text{w}$) glucose and 15% ($\text{w}\text{w}$) saturated and monounsaturated but no polyunsaturated fat (hydrogenated cottonseed oil) over an 11-day period than in the livers of mice fed a standard laboratory mouse chow (Purina) diet. In contrast, when other lab chow-fed mice were fed an isocaloric diet containing 15% ($\text{w}\text{w}$) polyunsaturated fat (corn oil), no change in the specific activity of malic enzyme occurred over a similar period of time. Rocket immunoelectrophoresis performed on cytosols from both dietary groups demonstrated that the livers of mice consuming the hydrogenated cottonseed oil diet contained approximately three times more malic enzyme protein than did the livers from the corn oil-fed animals. In mice pulse-labeled with l-[4,5-³H]leucine, the rate of hepatic malic enzyme synthesis (relative to that for total protein) was approximately twofold greater in the hydrogenated cottonseed oil-fed mice than in their corn oil-fed counterparts whereas the rate of hepatic malic enzyme degradation was similar for both groups. Immunotitration of liver malic enzyme from hydrogenated cottonseed oil-fed and corn oil-fed mice revealed identical equivalence points, demonstrating that the catalytic efficiency of mouse liver malic enzyme had not been affected by the type of dietary fat administered. When total liver RNA, isolated from the hydrogenated cottonseed oil- and the corn oil-fed animals, was translated in cell-free translation systems (wheat germ extract and reticulocyte lysate) we found that both dietary treatments had resulted in an increase in the activity of malic enzyme messenger RNA. Furthermore, there were no significant differences between the two dietary groups in this regard. These results suggest that hepatic malic enzyme specific activity in high-carbohydrate polyunsaturated fat-fed mice is regulated principally by dietary-induced changes in the rate of enzyme synthesis and not by the activity of messenger RNA coding for the enzyme.